Neumora Therapeutics Inc.
NMRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$342.78M
Close$
$1.11
36% downside
Current Fair Value
36% downsideOvervalued by 36% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $342.78 Million |
|---|---|
| Enterprise Value | $196.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.45 |
| Beta | 3.05 |
| Outstanding Shares | 179,872,000 |
Return
| Return on Equity | -314.65% |
|---|---|
| Return on Assets | -144.53% |
| Return on Invested Capital | -181.62% |
Valuation & Multiples
| P/E Ratio | -1.5 |
|---|---|
| PEG | 7 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.87 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6122▲ 52.30% |
|---|---|
| Total Calls | 1,276,600▲ 817.76% |
| Total Puts | 781,500▲ 6202.42% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 43.08%▲ 4.09% |
|---|---|
| Total Invested | $137.25M▲ 21.51% |
| Investors Holding | 121▲ 14.00% |
ESG Score
No data